4//SEC Filing
Miles Darrin 4
Accession 0001439222-21-000023
CIK 0001439222other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 4:14 PM ET
Size
8.3 KB
Accession
0001439222-21-000023
Insider Transaction Report
Form 4
Miles Darrin
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common stock
2021-02-22+725→ 13,272 total - Tax Payment
Common stock
2021-02-22−215→ 13,057 total - Exercise/Conversion
Restricted stock units
2021-02-22−725→ 724 total→ Common stock (725 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001840076
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 4:14 PM ET
- Size
- 8.3 KB